205 related articles for article (PubMed ID: 37666666)
1. A new ferrocene derivative blocks K-Ras localization and function by oxidative modification at His95.
Rehl KM; Selvakumar J; Pitsch RL; Hoang D; Arumugam K; Harshman SW; Gorfe AA; Cho KJ
Life Sci Alliance; 2023 Nov; 6(11):. PubMed ID: 37666666
[TBL] [Abstract][Full Text] [Related]
2. A new ferrocene derivative blocks KRAS localization and function by oxidative modification at His95.
Rehl KM; Selvakumar J; Hoang D; Arumugam K; Gorfe AA; Cho KJ
bioRxiv; 2023 Mar; ():. PubMed ID: 37034642
[TBL] [Abstract][Full Text] [Related]
3. Selective killing of K-ras-transformed pancreatic cancer cells by targeting NAD(P)H oxidase.
Wang P; Sun YC; Lu WH; Huang P; Hu Y
Chin J Cancer; 2015 Apr; 34(4):166-76. PubMed ID: 25963558
[TBL] [Abstract][Full Text] [Related]
4. Blocking K-Ras Interaction With the Plasma Membrane Is a Tractable Therapeutic Approach to Inhibit Oncogenic K-Ras Activity.
Henkels KM; Rehl KM; Cho KJ
Front Mol Biosci; 2021; 8():673096. PubMed ID: 34222333
[TBL] [Abstract][Full Text] [Related]
5. Micro-RNA-155 is induced by K-Ras oncogenic signal and promotes ROS stress in pancreatic cancer.
Wang P; Zhu CF; Ma MZ; Chen G; Song M; Zeng ZL; Lu WH; Yang J; Wen S; Chiao PJ; Hu Y; Huang P
Oncotarget; 2015 Aug; 6(25):21148-58. PubMed ID: 26020803
[TBL] [Abstract][Full Text] [Related]
6. The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cells.
Xu D; Allsop SA; Witherspoon SM; Snider JL; Yeh JJ; Fiordalisi JJ; White CD; Williams D; Cox AD; Baines AT
Carcinogenesis; 2011 Apr; 32(4):488-95. PubMed ID: 21262926
[TBL] [Abstract][Full Text] [Related]
7. Regulation of PD-L1 expression in K-ras-driven cancers through ROS-mediated FGFR1 signaling.
Glorieux C; Xia X; He YQ; Hu Y; Cremer K; Robert A; Liu J; Wang F; Ling J; Chiao PJ; Huang P
Redox Biol; 2021 Jan; 38():101780. PubMed ID: 33171331
[TBL] [Abstract][Full Text] [Related]
8. Fendiline inhibits K-Ras plasma membrane localization and blocks K-Ras signal transmission.
van der Hoeven D; Cho KJ; Ma X; Chigurupati S; Parton RG; Hancock JF
Mol Cell Biol; 2013 Jan; 33(2):237-51. PubMed ID: 23129805
[TBL] [Abstract][Full Text] [Related]
9. Design and discovery of novel quinazolinedione-based redox modulators as therapies for pancreatic cancer.
Pathania D; Sechi M; Palomba M; Sanna V; Berrettini F; Sias A; Taheri L; Neamati N
Biochim Biophys Acta; 2014 Jan; 1840(1):332-43. PubMed ID: 23954204
[TBL] [Abstract][Full Text] [Related]
10. Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer.
Kang R; Xie Y; Zhang Q; Hou W; Jiang Q; Zhu S; Liu J; Zeng D; Wang H; Bartlett DL; Billiar TR; Zeh HJ; Lotze MT; Tang D
Cell Res; 2017 Jul; 27(7):916-932. PubMed ID: 28374746
[TBL] [Abstract][Full Text] [Related]
11. Chalcones bearing a 3,4,5-trimethoxyphenyl motif are capable of selectively inhibiting oncogenic K-Ras signaling.
Kovar SE; Fourman C; Kinstedt C; Williams B; Morris C; Cho KJ; Ketcha DM
Bioorg Med Chem Lett; 2020 Jun; 30(11):127144. PubMed ID: 32276831
[TBL] [Abstract][Full Text] [Related]
12. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.
DeNicola GM; Karreth FA; Humpton TJ; Gopinathan A; Wei C; Frese K; Mangal D; Yu KH; Yeo CJ; Calhoun ES; Scrimieri F; Winter JM; Hruban RH; Iacobuzio-Donahue C; Kern SE; Blair IA; Tuveson DA
Nature; 2011 Jul; 475(7354):106-9. PubMed ID: 21734707
[TBL] [Abstract][Full Text] [Related]
13. Prx I suppresses K-ras-driven lung tumorigenesis by opposing redox-sensitive ERK/cyclin D1 pathway.
Park YH; Kim SU; Lee BK; Kim HS; Song IS; Shin HJ; Han YH; Chang KT; Kim JM; Lee DS; Kim YH; Choi CM; Kim BY; Yu DY
Antioxid Redox Signal; 2013 Aug; 19(5):482-96. PubMed ID: 23186333
[TBL] [Abstract][Full Text] [Related]
14. An oxanthroquinone derivative that disrupts RAS plasma membrane localization inhibits cancer cell growth.
Tan L; Cho KJ; Neupane P; Capon RJ; Hancock JF
J Biol Chem; 2018 Aug; 293(35):13696-13706. PubMed ID: 29970615
[TBL] [Abstract][Full Text] [Related]
15. Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress.
Shaw AT; Winslow MM; Magendantz M; Ouyang C; Dowdle J; Subramanian A; Lewis TA; Maglathin RL; Tolliday N; Jacks T
Proc Natl Acad Sci U S A; 2011 May; 108(21):8773-8. PubMed ID: 21555567
[TBL] [Abstract][Full Text] [Related]
16. Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis.
Lebedeva IV; Su ZZ; Sarkar D; Gopalkrishnan RV; Waxman S; Yacoub A; Dent P; Fisher PB
Oncogene; 2005 Jan; 24(4):585-96. PubMed ID: 15580305
[TBL] [Abstract][Full Text] [Related]
17. Glucose-6-Phosphate Dehydrogenase Is Not Essential for K-Ras-Driven Tumor Growth or Metastasis.
Ghergurovich JM; Esposito M; Chen Z; Wang JZ; Bhatt V; Lan T; White E; Kang Y; Guo JY; Rabinowitz JD
Cancer Res; 2020 Sep; 80(18):3820-3829. PubMed ID: 32661137
[TBL] [Abstract][Full Text] [Related]
18. The impact of oncogenic RAS on redox balance and implications for cancer development.
Lim JKM; Leprivier G
Cell Death Dis; 2019 Dec; 10(12):955. PubMed ID: 31852884
[TBL] [Abstract][Full Text] [Related]
19. Deletion of Pim kinases elevates the cellular levels of reactive oxygen species and sensitizes to K-Ras-induced cell killing.
Song JH; An N; Chatterjee S; Kistner-Griffin E; Mahajan S; Mehrotra S; Kraft AS
Oncogene; 2015 Jul; 34(28):3728-36. PubMed ID: 25241892
[TBL] [Abstract][Full Text] [Related]
20. Dual phosphoinositide 3-kinase/mammalian target of rapamycin blockade is an effective radiosensitizing strategy for the treatment of non-small cell lung cancer harboring K-RAS mutations.
Konstantinidou G; Bey EA; Rabellino A; Schuster K; Maira MS; Gazdar AF; Amici A; Boothman DA; Scaglioni PP
Cancer Res; 2009 Oct; 69(19):7644-52. PubMed ID: 19789349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
